Wako, Japan

Kenward Vong

This inventor holds 1 USPTO granted patent. Top assignee: Glytech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenward Vong. Retrieved from https://idiyas.com/inventor/kenward-vong-cwfj84uj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenward Vong: Innovator in Artificial Protein Catalysts

Introduction

Kenward Vong is a notable inventor based in Wako, Japan. He has made significant contributions to the field of synthetic chemistry, particularly through his innovative work on artificial protein catalysts. His research focuses on developing solutions that enhance therapeutic applications in vivo.

Latest Patents

Kenward Vong holds a patent for an artificial protein catalyst. The problem addressed by this invention is the need for a novel catalyst that can be protected from substances in vivo. The solution provided involves a complex of a protein and a catalyst, which can be either a metal or organic catalyst. This complex features a protein with a hydrophobic pocket that houses the catalyst, ensuring that it is not exposed to a hydrophilic environment. This innovation has potential usefulness in therapeutic in vivo synthetic chemistry.

Career Highlights

Kenward Vong is currently associated with Glytech, Inc., where he continues to advance his research in the field of synthetic chemistry. His work has garnered attention for its potential applications in medical and therapeutic settings.

Collaborations

Kenward has collaborated with notable colleagues, including Katsunori Tanaka and Taiji Shimoda. These collaborations have contributed to the development and refinement of his innovative ideas.

Conclusion

Kenward Vong's work in artificial protein catalysts represents a significant advancement in synthetic chemistry. His innovative approach has the potential to impact therapeutic applications positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…